EP3621595A4 - DOSAGE FORM IN FILM FORM WITH SUSTAINED-RELEASE MUCOADHESIVE PARTICLES - Google Patents
DOSAGE FORM IN FILM FORM WITH SUSTAINED-RELEASE MUCOADHESIVE PARTICLES Download PDFInfo
- Publication number
- EP3621595A4 EP3621595A4 EP18798869.6A EP18798869A EP3621595A4 EP 3621595 A4 EP3621595 A4 EP 3621595A4 EP 18798869 A EP18798869 A EP 18798869A EP 3621595 A4 EP3621595 A4 EP 3621595A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- sustained
- dosage form
- mucoadhesive particles
- release mucoadhesive
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/588,897 US10272038B2 (en) | 2013-12-02 | 2017-05-08 | Film dosage form with extended release mucoadhesive particles |
| PCT/CA2018/050542 WO2018205017A1 (en) | 2017-05-08 | 2018-05-08 | Film dosage form with extended release mucoadhesive particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3621595A1 EP3621595A1 (en) | 2020-03-18 |
| EP3621595A4 true EP3621595A4 (en) | 2021-04-07 |
Family
ID=64104064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP18798869.6A Pending EP3621595A4 (en) | 2017-05-08 | 2018-05-08 | DOSAGE FORM IN FILM FORM WITH SUSTAINED-RELEASE MUCOADHESIVE PARTICLES |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3621595A4 (en) |
| CA (1) | CA3062704A1 (en) |
| WO (1) | WO2018205017A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11273105B2 (en) * | 2017-06-16 | 2022-03-15 | Sorse Technology Corporation | Method for preparing solid forms of plant extract |
| US10828254B2 (en) | 2018-09-28 | 2020-11-10 | Intelgenx Corp. | Oral film formulation for modulating absorption profile |
| US12303501B2 (en) | 2018-11-05 | 2025-05-20 | Intelgenx Corp. | Lipophilic active oral film formulation and method of making the same |
| BR112022002479A2 (en) * | 2019-08-12 | 2022-04-26 | Tenshi Kaizen Private Ltd | Pharmaceutical composition and process for preparing solid oral cannabinoid composition into rapidly disintegrating lyophilized tablets |
| KR102044515B1 (en) * | 2019-08-20 | 2019-11-14 | 이영환 | Sustained release type orally disintegrating film with excellant oral mucoadhesion and the manufacturing method thereof |
| US12440472B2 (en) | 2021-06-16 | 2025-10-14 | Intelgenx Corp. | Stable tryptamine oral films |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002051382A2 (en) * | 2000-12-27 | 2002-07-04 | University Of Kentucky Research Foundation | Ph-sensitive mucoadhesive film-forming gels and wax-film composites |
| WO2005009386A2 (en) * | 2003-07-24 | 2005-02-03 | Smithkline Beecham Corporation | Orally dissolving films |
| WO2010104464A1 (en) * | 2009-03-13 | 2010-09-16 | Excellens Tech. Products Aps | Oral delivery product |
| US20110305768A1 (en) * | 2008-07-01 | 2011-12-15 | The Johns Hopkins University | Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
| US20160051510A1 (en) * | 2014-07-28 | 2016-02-25 | Eric Allen | Oral dissolvable film that includes plant extract |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9668970B2 (en) * | 2013-12-02 | 2017-06-06 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
-
2018
- 2018-05-08 WO PCT/CA2018/050542 patent/WO2018205017A1/en not_active Ceased
- 2018-05-08 CA CA3062704A patent/CA3062704A1/en active Pending
- 2018-05-08 EP EP18798869.6A patent/EP3621595A4/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002051382A2 (en) * | 2000-12-27 | 2002-07-04 | University Of Kentucky Research Foundation | Ph-sensitive mucoadhesive film-forming gels and wax-film composites |
| WO2005009386A2 (en) * | 2003-07-24 | 2005-02-03 | Smithkline Beecham Corporation | Orally dissolving films |
| US20110305768A1 (en) * | 2008-07-01 | 2011-12-15 | The Johns Hopkins University | Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
| WO2010104464A1 (en) * | 2009-03-13 | 2010-09-16 | Excellens Tech. Products Aps | Oral delivery product |
| US20160051510A1 (en) * | 2014-07-28 | 2016-02-25 | Eric Allen | Oral dissolvable film that includes plant extract |
Non-Patent Citations (2)
| Title |
|---|
| SALAMAT-MILLER N ET AL: "The use of mucoadhesive polymers in buccal drug delivery", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM , NL, vol. 57, no. 11, 3 November 2005 (2005-11-03), pages 1666 - 1691, XP027771408, ISSN: 0169-409X, [retrieved on 20051103] * |
| See also references of WO2018205017A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3621595A1 (en) | 2020-03-18 |
| WO2018205017A1 (en) | 2018-11-15 |
| CA3062704A1 (en) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3621595A4 (en) | DOSAGE FORM IN FILM FORM WITH SUSTAINED-RELEASE MUCOADHESIVE PARTICLES | |
| EP3549589A4 (en) | PHARMACEUTICAL COMPOSITION WITH MITOCHONDRIA | |
| EP3629765A4 (en) | DOSAGE DELIVERY FILM | |
| EP3513809A4 (en) | MEDICINAL COMPOSITION | |
| EP3426346A4 (en) | PARTICLE ARCTHERAPY | |
| EP3436251A4 (en) | POST-PROCESSING IN 3D PRINTING SYSTEMS | |
| DK3655017T3 (en) | PHARMACEUTICAL COMPOSITION | |
| JP2018533683A5 (en) | ||
| DK3532029T3 (en) | Liquid pharmaceutical composition | |
| EP3431561A4 (en) | COATING FILM AND HIGHLY DURABLE ANTIBUID COATING COMPOSITION | |
| EP3526422A4 (en) | DIMENSIONALLY STABLE FLOOR PLATE | |
| EP3383967A4 (en) | SOLID ENHANCING INHIBITORS WITH CONTROLLED RELEASE | |
| EP3785698A4 (en) | EDARAVON PHARMACEUTICAL COMPOSITION | |
| EP3435984A4 (en) | POSITIVE DOSAGE FORMS WITH EXTENDED RELEASE | |
| EP3267987A4 (en) | CHEMICALLY MODIFIED CURCUMINES FOR USE IN THE PRODUCTION OF LIPOXINS | |
| KR101724996B9 (en) | Metal plate and deposition mask using the same | |
| EP3583943A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3561009A4 (en) | EASY PELER COATING COMPOSITION | |
| EP3646867C0 (en) | PHARMACEUTICAL COMPOSITION | |
| BR112018005299A2 (en) | Alkenylphenoxy substituted 1,1-diphenylethylenes, processes for their preparation and use | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3786193A4 (en) | PARTICLES | |
| EP3630074C0 (en) | TAPENTADOL SUSTAINED-RELEASE ORAL MULTI-PARTICLE DOSAGE FORM | |
| IL282157A (en) | Compounds and their medicinal uses | |
| EP3616722A4 (en) | PHARMACEUTICAL COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20191127 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20210304 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 36/18 20060101ALI20210226BHEP Ipc: A61K 9/10 20060101AFI20210226BHEP Ipc: A61K 9/14 20060101ALI20210226BHEP Ipc: A61K 9/00 20060101ALI20210226BHEP Ipc: A61K 47/06 20060101ALI20210226BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20220825 |